tag commercial-content 
Pharmaceutical Technology
NOVEMBER 9, 2022
In its October 28 quarterly Securities and Exchange Commission (SEC) filing, the company said that Roctavian’s commercial launch is now underway. million price tag. Editorial content is independently produced and follows the highest standards of journalistic integrity. million ($1.5 million ($1.8 million at the time).
Intouch Solutions
APRIL 11, 2024
Commercial : Improved experience and communication between patients and doctors. This process is relatively straightforward when high-value medical-scientific content is readily available. However, in cases where such content is missing, it becomes necessary to grant access to a wide array of materials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 31, 2021
Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. —- End —-.
The Pharma Data
JANUARY 31, 2021
Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. . EMERYVILLE, Calif.
pharmaphorum
MAY 24, 2021
Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. Robb DeFilippis. Doing more in the digital space.
Pharmaceutical Technology
JUNE 21, 2023
The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment.
The Pharma Data
NOVEMBER 15, 2020
Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials. In addition, this will meet Clover’s Phase 2/3 clinical production plan and commercial readiness once its vaccine candidate is approved. View original content to download multimedia: [link]. SOURCE Cytiva.
Expert insights. Personalized for you.
278 
Let's personalize your content